Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

LONE TREE, Colo., May 3, 2021 /PRNewswire/ -- Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital ...

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...

In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$240.00. The company’s shares closed ...

Cochlear further supports Audio Streaming for Hearing Aids (ASHA) standard to enable direct streaming from Fire TV devices to a Cochlear™ hearing implant for the first time. LONE TREE, Colo., Feb. 22, ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ -- In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a continuation of its share buy-back program, purchasing 2,500 shares on the previous day, adding to the 44,500 already ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...